Skip to content

Efficacy of Buccal Pad of Fat, Advanced Platelet Rich Fibrin, Fibrin Glue and Oxidized Cellulose Plug in Management of Oro-Antral Communication, Comparative Clinical Study

Efficacy of Buccal Pad of Fat, Advanced Platelet Rich Fibrin, Fibrin Glue and Oxidized Cellulose Plug in Management of Oro-Antral Communication, Comparative Clinical Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06220877
Acronym
OAC
Enrollment
24
Registered
2024-01-24
Start date
2019-01-01
Completion date
2023-06-01
Last updated
2024-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers Only

Keywords

Benacel;, bone regeneration;, platelet rich growth factor;, Oro-Antral Communication, buccal pad of fat, fibrin glue

Brief summary

Evaluation of the efficacy of different treatment protocols in the management of Oro-Antral Communications.

Detailed description

the current study was carried on 24 patients suffering from Oro-Antral Communications. All patients were divided into 4 equal groups.

Interventions

PROCEDUREBuccal Pad of Fat

surgical procedure

PROCEDUREA-PRF

blood sample

PROCEDUREfibrin glue

procedure

PROCEDUREoxidized cellulose

procedure

Sponsors

October 6 University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* patients suffering from oroantral communications * patients suffering from oroantral fistula. * The Diameter of the opening ranged from 4-9 mm, * communication resulted from recent extraction, * foreign body; or * cyst enucleation

Exclusion criteria

Patients suffering from any systemic diseases were excluded from the study. * diabetes, * autoimmune diseases, * cancers, * nephropathy, * coagulation disorders

Design outcomes

Primary

MeasureTime frameDescription
o Recurrence6 monthspresence or absence

Secondary

MeasureTime frameDescription
pain, visual analog scale4 weeks0 no pain, 10 severe pain

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026